Anti–high mobility group box 1 monoclonal antibody improves ischemia/reperfusion injury and mode of liver regeneration after partial hepatectomy
Masahiro Sugihara(Okayama University), Toshiyoshi Fujiwara(Okayama University), Ryuichi Yoshida(Okayama University), Masashi Utsumi(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Masahiro Nishibori(Okayama University), Takeshi Nagasaka(Okayama University), Yasuharu Sato(Okayama University), Yuzo Umeda(Okayama University), Kyotaro Ohno(Okayama University), Susumu Shinoura(Okayama University), Takahito Yagi(Okayama University), Tadashi Yoshino(Okayama University), Hiroshi Sadamori(Okayama University), Hideo Takahashi(Kindai University), Hiroshi Tazawa(Okayama University)
Cited by 17
Related Papers
Tumor-suppressive <i>miR-34a</i> induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
|Proceedings of the National Academy of Sciences|2007|902
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304